Cargando…

Online error rate control for platform trials

Platform trials evaluate multiple experimental treatments under a single master protocol, where new treatment arms are added to the trial over time. Given the multiple treatment comparisons, there is the potential for inflation of the overall type I error rate, which is complicated by the fact that...

Descripción completa

Detalles Bibliográficos
Autores principales: Robertson, David S., Wason, James M. S., König, Franz, Posch, Martin, Jaki, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7614610/
https://www.ncbi.nlm.nih.gov/pubmed/37005003
http://dx.doi.org/10.1002/sim.9733
_version_ 1783605626910277632
author Robertson, David S.
Wason, James M. S.
König, Franz
Posch, Martin
Jaki, Thomas
author_facet Robertson, David S.
Wason, James M. S.
König, Franz
Posch, Martin
Jaki, Thomas
author_sort Robertson, David S.
collection PubMed
description Platform trials evaluate multiple experimental treatments under a single master protocol, where new treatment arms are added to the trial over time. Given the multiple treatment comparisons, there is the potential for inflation of the overall type I error rate, which is complicated by the fact that the hypotheses are tested at different times and are not necessarily pre-specified. Online error rate control methodology provides a possible solution to the problem of multiplicity for platform trials where a relatively large number of hypotheses are expected to be tested over time. In the online multiple hypothesis testing framework, hypotheses are tested one-by-one over time, where at each time-step an analyst decides whether to reject the current null hypothesis without knowledge of future tests but based solely on past decisions. Methodology has recently been developed for online control of the false discovery rate as well as the familywise error rate (FWER). In this paper, we describe how to apply online error rate control to the platform trial setting, present extensive simulation results, and give some recommendations for the use of this new methodology in practice. We show that the algorithms for online error rate control can have a substantially lower FWER than uncorrected testing, while still achieving noticeable gains in power when compared with the use of a Bonferroni correction. We also illustrate how online error rate control would have impacted a currently ongoing platform trial.
format Online
Article
Text
id pubmed-7614610
institution National Center for Biotechnology Information
language English
publishDate 2023
record_format MEDLINE/PubMed
spelling pubmed-76146102023-06-30 Online error rate control for platform trials Robertson, David S. Wason, James M. S. König, Franz Posch, Martin Jaki, Thomas Stat Med Article Platform trials evaluate multiple experimental treatments under a single master protocol, where new treatment arms are added to the trial over time. Given the multiple treatment comparisons, there is the potential for inflation of the overall type I error rate, which is complicated by the fact that the hypotheses are tested at different times and are not necessarily pre-specified. Online error rate control methodology provides a possible solution to the problem of multiplicity for platform trials where a relatively large number of hypotheses are expected to be tested over time. In the online multiple hypothesis testing framework, hypotheses are tested one-by-one over time, where at each time-step an analyst decides whether to reject the current null hypothesis without knowledge of future tests but based solely on past decisions. Methodology has recently been developed for online control of the false discovery rate as well as the familywise error rate (FWER). In this paper, we describe how to apply online error rate control to the platform trial setting, present extensive simulation results, and give some recommendations for the use of this new methodology in practice. We show that the algorithms for online error rate control can have a substantially lower FWER than uncorrected testing, while still achieving noticeable gains in power when compared with the use of a Bonferroni correction. We also illustrate how online error rate control would have impacted a currently ongoing platform trial. 2023-04-02 2023-04-02 /pmc/articles/PMC7614610/ /pubmed/37005003 http://dx.doi.org/10.1002/sim.9733 Text en https://creativecommons.org/licenses/by/4.0/This work is licensed under a CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/) International license.
spellingShingle Article
Robertson, David S.
Wason, James M. S.
König, Franz
Posch, Martin
Jaki, Thomas
Online error rate control for platform trials
title Online error rate control for platform trials
title_full Online error rate control for platform trials
title_fullStr Online error rate control for platform trials
title_full_unstemmed Online error rate control for platform trials
title_short Online error rate control for platform trials
title_sort online error rate control for platform trials
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7614610/
https://www.ncbi.nlm.nih.gov/pubmed/37005003
http://dx.doi.org/10.1002/sim.9733
work_keys_str_mv AT robertsondavids onlineerrorratecontrolforplatformtrials
AT wasonjamesms onlineerrorratecontrolforplatformtrials
AT konigfranz onlineerrorratecontrolforplatformtrials
AT poschmartin onlineerrorratecontrolforplatformtrials
AT jakithomas onlineerrorratecontrolforplatformtrials